Rapaflo (silodosin), a new selective alpha-blocker for benign prostatic hyperplasia (BPH)

May 2009

Reps are promoting Rapaflo (silodosin), a new selective alpha-blocker for benign prostatic hyperplasia (BPH).

Think of it as similar to Flomax (tamsulosin).

Rapaflo and Flomax are more selective for alpha receptors that relax the bladder and prostate...instead of lowering blood pressure.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote